Future Forecasts for Europe Continuous Glucose Monitoring Market Industry Growth

Key Insights

The European Continuous Glucose Monitoring (CGM) market is experiencing robust growth, projected to reach €2.04 billion in 2025 and exhibiting a Compound Annual Growth Rate (CAGR) of 11.33% from 2025 to 2033. This expansion is fueled by several key factors. The increasing prevalence of diabetes, particularly Type 1 and Type 2, across major European nations like Germany, France, and the UK, forms a significant driver. Furthermore, advancements in CGM technology, leading to smaller, more accurate, and user-friendly devices, are boosting market adoption. Improved integration with insulin pumps and mobile applications enhances convenience and efficacy for patients, contributing to market growth. Growing awareness of the benefits of CGM in preventing severe hypoglycemic events and improving overall diabetes management is also a crucial factor. The market is segmented into sensors and durables, with sensors holding a larger market share due to their consumable nature. Leading players like Medtronic, Abbott, Dexcom, Senseonics, and Ascensia are driving innovation and competition, fostering market expansion.

Significant regional variations exist within Europe. Germany, France, the UK, and Italy are expected to dominate the market due to their larger diabetic populations and well-established healthcare infrastructures. However, growth potential is also significant in other regions like the Netherlands and Sweden, driven by increasing healthcare expenditure and rising diabetes prevalence. The market faces some restraints, including the high cost of CGM systems, which can pose a barrier to access, particularly for patients in lower-income demographics. Nevertheless, the overall outlook remains positive, with the market expected to experience substantial growth throughout the forecast period (2025-2033), driven by technological advancements, improved patient outcomes, and increasing government initiatives to support diabetes management.

Europe Continuous Glucose Monitoring (CGM) Market: A Comprehensive Report (2019-2033)

This in-depth report provides a comprehensive analysis of the Europe Continuous Glucose Monitoring (CGM) market, encompassing market dynamics, growth trends, regional performance, product landscape, key players, and future outlook. The study period covers 2019-2033, with 2025 as the base and estimated year. The report segments the market into key areas: Continuous Glucose Monitoring (CGM): Sensors and Durables, offering granular insights into market size and growth potential across these sub-segments. The report leverages extensive primary and secondary research to provide actionable intelligence for industry professionals.

Europe Continuous Glucose Monitoring Market Dynamics & Structure

The European CGM market is characterized by a moderately concentrated landscape, with key players like Medtronic, Abbott, Dexcom, Senseonics, and Ascensia holding significant market share. The "Other Company Share Analyse" segment accounts for xx Million units, reflecting the presence of numerous smaller players and emerging companies. Market concentration is expected to remain relatively stable, although mergers and acquisitions (M&A) activity could reshape the competitive dynamics.

• Market Concentration: Medtronic and Abbott hold a combined xx% market share in 2025, while Dexcom accounts for xx%. The remaining market share is divided among Senseonics, Ascensia, and other smaller players.
• Technological Innovation: Continuous advancements in sensor technology, miniaturization, improved accuracy, and integration with mobile applications are key drivers of market growth. Innovation barriers include the high cost of research and development, stringent regulatory requirements, and the need for robust clinical trials.
• Regulatory Framework: The CE Mark approval process for CGM devices within the EU influences market entry and adoption. Harmonization of regulatory requirements across different EU member states could further stimulate market growth.
• Competitive Product Substitutes: Traditional blood glucose meters (BGMs) remain a competitive substitute, although the convenience and continuous monitoring capabilities of CGM systems are driving market shift.
• End-User Demographics: The increasing prevalence of diabetes, particularly type 1 and type 2 diabetes, across Europe is a primary driver of CGM market expansion. Growing awareness about the benefits of CGM among both patients and healthcare providers further boosts adoption.
• M&A Trends: The number of M&A deals in the European CGM market averaged xx per year during the historical period (2019-2024). Consolidation among market players is expected to continue, driven by the need for expansion into new markets and technology acquisition.

Europe Continuous Glucose Monitoring Market Growth Trends & Insights

The European CGM market exhibited robust growth during the historical period (2019-2024), expanding at a CAGR of xx%. This growth is attributed to several factors, including rising diabetes prevalence, increased awareness of CGM benefits, technological advancements leading to improved accuracy and ease of use, and favorable reimbursement policies in several countries. The market is projected to continue its growth trajectory during the forecast period (2025-2033), with a projected CAGR of xx%, reaching xx Million units by 2033. Market penetration is currently at xx% and is expected to increase to xx% by 2033, driven by increased adoption among patients with type 2 diabetes and broader reimbursement coverage. Technological disruptions, such as the introduction of implantable CGM systems and integration with smart insulin pumps, will further accelerate market expansion. Consumer behavior shifts towards proactive diabetes management and personalized healthcare are also contributing to market growth.

Dominant Regions, Countries, or Segments in Europe Continuous Glucose Monitoring Market

Germany, France, and the United Kingdom represent the largest markets within Europe for CGM systems, driven by high diabetes prevalence, robust healthcare infrastructure, and favorable reimbursement policies. The Continuous Glucose Monitoring: Sensors segment holds the largest market share (xx%) and is projected to maintain its dominance, driven by the ongoing demand for disposable sensors. Continuous Glucose Monitoring: Durables segment will grow steadily, fueled by the increasing adoption of reusable CGM components.

• Key Drivers: Strong healthcare infrastructure, high diabetes prevalence, favorable reimbursement policies, and early adoption of new technologies are key drivers for market dominance in Germany, France, and the UK.
• Dominance Factors: High healthcare expenditure, a significant population with diabetes, and the presence of major CGM manufacturers and distributors contribute to the market dominance of these countries. Growth potential in other regions depends on increased access to healthcare, improved diabetes awareness programs, and expanding reimbursement coverage.

Europe Continuous Glucose Monitoring Market Product Landscape

The CGM market features a range of products, including traditional finger-stick-requiring sensors and flash glucose monitoring (FGM) devices. Recent innovations focus on improving accuracy, reducing the need for calibration, extending sensor lifespan, and enhancing data integration with other diabetes management tools. Key selling propositions for CGM systems are convenience, continuous monitoring of glucose levels, and the ability to provide actionable insights for better diabetes management.

Key Drivers, Barriers & Challenges in Europe Continuous Glucose Monitoring Market

Key Drivers: The rising prevalence of diabetes, technological advancements leading to improved accuracy and user-friendliness, increased patient awareness of CGM benefits, and expanding reimbursement coverage are key growth drivers.

Key Barriers & Challenges: High cost of CGM systems, limited insurance coverage in some countries, potential sensor accuracy issues, and the need for ongoing calibration can hamper market adoption. Supply chain disruptions and competition from established BGM players pose additional challenges. Regulatory hurdles and varying reimbursement policies across EU countries can also significantly impact market growth.

Emerging Opportunities in Europe Continuous Glucose Monitoring Market

Emerging opportunities include the expansion of CGM use into new patient populations (e.g., gestational diabetes), integration with artificial pancreas systems, development of more accurate and less invasive sensors, and the growth of remote patient monitoring. Furthermore, increasing emphasis on personalized medicine offers opportunities for customized CGM solutions.

Growth Accelerators in the Europe Continuous Glucose Monitoring Market Industry

Technological advancements like implantable sensors and improved data analytics capabilities will be significant growth catalysts. Strategic partnerships between CGM manufacturers and telehealth providers, as well as market expansion into underserved populations, will further propel market growth. Innovative business models, such as subscription-based services and bundled solutions, could also drive market expansion.

Key Players Shaping the Europe Continuous Glucose Monitoring Market Market

• Medtronic
• Abbott
• Other Company Share Analyse
• Dexcom
• Senseonics
• Ascensia

Notable Milestones in Europe Continuous Glucose Monitoring Market Sector

• October 2023: Medtronic introduces Simplera, a cutting-edge CGM for individuals with diabetes aged 2 and above. This launch signifies a move toward more user-friendly and accessible CGM technology.
• June 2022: Ascensia Diabetes Care announces CE Mark approval for the Eversense E3 CGM System, expanding market access within the EU. This approval demonstrates regulatory confidence in the technology and its potential to benefit a wider patient population.

In-Depth Europe Continuous Glucose Monitoring Market Market Outlook

The European CGM market is poised for sustained growth, driven by technological innovations, expanding reimbursement policies, and increased patient awareness. Strategic partnerships and collaborations among industry players will further accelerate market expansion. Companies focusing on developing accurate, affordable, and user-friendly CGM systems, alongside those that improve data integration and analytics, are well-positioned to capitalize on the considerable market opportunities. The long-term outlook is positive, with significant potential for market expansion across various segments and geographies.

Europe Continuous Glucose Monitoring Market Segmentation

• 1. Continuous Glucose Monitoring
  • 1.1. Sensors
  • 1.2. Durables

Europe Continuous Glucose Monitoring Market Segmentation By Geography

• 1. France
• 2. Germany
• 3. Italy
• 4. Spain
• 5. Russia
• 6. United Kingdom
• 7. Rest of Europe